FHI vs AUB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 04, 2026

FHI

39.5
AI Score
VS
FHI Wins

AUB

35.7
AI Score

Investment Advisor Scores

FHI

40score
Recommendation
SELL

AUB

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric FHI AUB Winner
Net Income 403.30M 419.81M AUB
ROE 33.7% 8.3% FHI
ROA 18.1% 1.1% FHI
Total Assets 2.23B 38.35B AUB
Cash 582.54M 700.76M AUB
Debt/Equity 0.29 0.17 AUB

Relative Price Performance (Last 90 Days)

FHI 1M: +14.4% · 3M: +1.3% AUB 1M: +3.7% · 3M: -5.5%

Current Technical Phase

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 68.2 · Price: $63.99

AUB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.2 · Price: $39.34

Fundamentals Snapshot

Metric FHI AUB
Market Cap — —
Forward P/E 10.7 9.7
Trailing P/E 11.9 10.9
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.7% 1.0%
Operating Margin 0.3% 0.5%
EPS 5.39 3.61
Dividend Yield 0.02% 0.04%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.